Details for New Drug Application (NDA): 203801
✉ Email this page to a colleague
The generic ingredient in FLUDEOXYGLUCOSE F18 is fludeoxyglucose f-18. There are eight drug master file entries for this compound. Twenty-six suppliers are listed for this compound. Additional details are available on the fludeoxyglucose f-18 profile page.
Summary for 203801
Tradename: | FLUDEOXYGLUCOSE F18 |
Applicant: | Trustees Univ Pa |
Ingredient: | fludeoxyglucose f-18 |
Patents: | 0 |
Pharmacology for NDA: 203801
Mechanism of Action | Radiopharmaceutical Activity |
Suppliers and Packaging for NDA: 203801
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
FLUDEOXYGLUCOSE F18 | fludeoxyglucose f-18 | INJECTABLE;INTRAVENOUS | 203801 | ANDA | Trustees of the University of Pennsylvania | 40098-101 | 40098-101-19 | 25 mL in 1 VIAL, MULTI-DOSE (40098-101-19) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INTRAVENOUS | Strength | 20-200mCi/ML | ||||
Approval Date: | Oct 29, 2014 | TE: | AP | RLD: | No |
Complete Access Available with Subscription